News & Announcements

Fund: HQL

  1. Tekla Funds Announce Adjournment of Special Meetings and Implore Shareholders to Vote Their Shares Immediately

    September 13, 2023

    BOSTON, MA (September 12, 2023) – Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special… Read Full Post

  2. Tekla Funds Announce Second Adjournment of Special Meetings and Urge Shareholder Participation to Limit the Need for Further Solicitation Effort

    August 30, 2023

    BOSTON, MA (August 29, 2023) – Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint first special… Read Full Post

  3. Tekla Life Sciences Investors Declares Distribution

    August 15, 2023

    BOSTON, MA, August 15, 2023 – On August 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.32 per share. The record date for the distribution is August 25, 2023 and the payable date is September 29, 2023. The Fund will trade… Read Full Post

  4. Tekla Funds Announce Adjournment of Special Meetings

    August 14, 2023

    BOSTON, MA (August 14, 2023) – Tekla Healthcare Investors (HQH), Tekla Life Sciences Investors (HQL), Tekla Healthcare Opportunities Fund (THQ) and Tekla World Healthcare Fund (THW), (the “Funds”) today announced that their joint special meetings of… Read Full Post

  5. Tekla Life Sciences Investors Paid Distribution

    June 30, 2023

    BOSTON, MA, June 30, 2023 – On June 30, 2023, Tekla Life Sciences Investors paid a distribution of $0.32 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this… Read Full Post

  6. Tekla Capital Management LLC Announces Proposed Transaction

    June 20, 2023

    BOSTON—Tekla Capital Management LLC (Tekla) announced today that it has entered into an agreement with abrdn Inc. for a strategic transaction involving four NYSE-listed healthcare & biotech thematic closed-end funds (the Funds), totaling $3.1 bn… Read Full Post

  7. Tekla Life Sciences Investors Declares Distribution

    May 15, 2023

    BOSTON, MA, May 15, 2023 – On May 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.32 per share. The record date for the distribution is May 25, 2023 and the payable date is June 30, 2023. The Fund will trade ex-distribution on… Read Full Post

  8. Tekla Life Sciences Investors Paid Distribution

    March 31, 2023

    BOSTON, MA, March 31, 2023 – On March 31, 2023, Tekla Life Sciences Investors paid a distribution of $0.33 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this… Read Full Post

  9. Tekla Life Sciences Investors Announce Renewal of Share Repurchase Program

    March 16, 2023

    BOSTON, MA, March 16, 2023 – Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program.  The current share repurchase program allows the Fund to purchase in the open… Read Full Post

  10. Tekla Life Sciences Investors Declares Distribution

    February 15, 2023

    BOSTON, MA, February 15, 2023 – On February 15, 2023, Tekla Life Sciences Investors declared a distribution of $0.33 per share. The record date for the distribution is February 27, 2023 and the payable date is March 31, 2023. The Fund will trade… Read Full Post

« Newer Page 1 of 9 Older »

© 2023 Tekla Capital Management LLC | All rights reserved | Legal Disclaimer

The material contained on this website is not intended to be a recommendation or investment advice, does not constitute a solicitation to buy or sell securities, and is not provided in a fiduciary capacity. The information provided does not take into account the specific objectives or circumstances of any particular investor, or suggest any specific course of action. Investment decisions should be made based on an investor’s objectives and circumstances and in consultation with his or her advisors.

There can be no assurance that any closed-end fund will achieve its investment objective(s). Past performance does not guarantee future results. The net asset value of any closed-end fund will fluctuate with the value of the underlying securities. Historically closed-end funds have often traded at a discount to their net asset value. The distribution rate and income amounts reflect past amounts distributed and may not be indicative of future rates or income amounts. Distribution rates and income amounts can change at any time.

Investors should consider the investment objective and policies, risk considerations, charges and ongoing expenses of an investment carefully before investing. For more information, please contact your marketing and distribution agent, Destra Capital Advisors LLC at 877.855.3434.

NOT FDIC-INSURED | NOT BANK-GUARANTEED | MAY LOSE VALUE

social sharing image for Tekla Capital Management LLC website